Bo Li
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
Papers in
- Surgery 61
- Organ Transplantation Techniques and Outcomes 18
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
-
- Extracellular vesicles in disease 9
- RNA modifications and cancer 7
- Co-authors
- Longjiang Li (30 shared papers)Zhijie Weng (5 shared papers)Chenzhou Wu (5 shared papers)Zhihe Zhao (14 shared papers)Yonggang Wei (19 shared papers)Takehito Ouchi (9 shared papers)Bo Han (1 shared paper)Bowen Zhang (1 shared paper)
- Journals
- PLoS ONE (6 papers)Medicine (6 papers)Frontiers in Oncology (5 papers)Oncotarget (4 papers)Journal of Surgical Research (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Bo Li
221 papers receiving 4.6k citations
Bo Li's Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 740
- Hepatology 239
- Oncology 833
- Otorhinolaryngology 118
- Genetics 281
Countries citing papers authored by Bo Li
This map shows the geographic impact of Bo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Li more than expected).
Fields of papers citing papers by Bo Li
This network shows the impact of papers produced by Bo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Li. The network helps show where Bo Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 241 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer Hit paper breakdown → | 2021 | 290 |
| 2 | 2021 | 204 | |
| 3 | Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies Hit paper breakdown → | 2022 | 179 |
| 4 | 2020 | 172 | |
| 5 | 1996 | 126 | |
| 6 | 2020 | 117 | |
| 7 | 2015 | 100 | |
| 8 | 2010 | 84 | |
| 9 | 2006 | 80 | |
| 10 | 2014 | 80 | |
| 11 | 2014 | 74 | |
| 12 | 2006 | 68 | |
| 13 | 2021 | 66 | |
| 14 | 2018 | 66 | |
| 15 | 2021 | 63 | |
| 16 | 2019 | 61 | |
| 17 | 2008 | 56 | |
| 18 | 2014 | 54 | |
| 19 | 2015 | 54 | |
| 20 | 2015 | 54 |
About Bo Li
Bo Li is a scholar working on Surgery, Molecular Biology, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 241 papers that have together received 4.6k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (18 papers), Mesenchymal stem cell research (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), Extracellular vesicles in disease (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), RNA modifications and cancer (7 papers), Cancer-related Molecular Pathways (6 papers) and Head and Neck Cancer Studies (6 papers). The work is most often cited by research in Cancer Research (740 citations), Hepatology (239 citations), Oncology (833 citations), Otorhinolaryngology (118 citations) and Genetics (281 citations). Bo Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Longjiang Li, Zhijie Weng, Chenzhou Wu, Zhihe Zhao, Yonggang Wei, Takehito Ouchi, Bo Han, Bowen Zhang, Fanyuan Yu and Mingqing Xu. Their work appears in journals such as PLoS ONE, Medicine, Frontiers in Oncology, Oncotarget and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.